Clinical trials
Mesothelioma, Malignant trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
44 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2021 | 2 |
| 2023 | 5 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 7 |
| Unknown status | 6 |
| Active, not recruiting | 5 |
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 5 |
| Istituto Clinico Humanitas | 4 |
| AGC Biologics S.p.A. | 3 |
| Armando Santoro, MD | 3 |
| Azienda Ospedaliera Universitaria Senese | 2 |
| Istituto Oncologico Veneto IRCCS | 2 |
| Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2 |
| Mario Negri Institute for Pharmacological Research | 2 |
| NovoCure Ltd. | 2 |
| Alfacell | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 44 |
| Mesothelioma | 8 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colorectal Neoplasms | 2 |
| Lymphoma | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Melanoma | 2 |
| Ovarian Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Appendiceal Neoplasms | 1 |
Trials
Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.